1. von Schacky C, Angerer P, Kothny W, et al. The effect of dietary
omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind,
placebo-controlled trial. Ann Intern Med 1999;130:554-62. 2. Mate J, Castanos R, Garcia-Samaniego J, Pajares JM. Does dietary fish
oil maintain the remission of Crohn’s disease: a case control study.
Gastroenterology 1991;100:A228 [abstract]. 3. Kremer JM, Lawrence DA, Petrillow GF, et al. Effects of highdose fish
oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Arthritis
Rheum 1995;38:1107-14. 4. Donadio JV Jr, Bergstrahl EJ, Offord KP, et al. A controlled trial of
fish oil in IgA nephropathy. N Engl J Med 1994;331:1194-9. 5. Peck LW. Essential fatty acid deficiency in renal failure: can
supplements really help? J Am Diet Assoc 1997;97:5150-3. 6. Donadio JV Jr, Grande JP, Bergstralh EJ, et al. The long-term outcome
of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology
Collaborative Group. J Am Soc Nephrol 1999;10:1772-7. 7. Shahar E, Folsom AR, Melnick SL, et al. Dietary n-3 polyunsaturated
fatty acids and smoking-related chronic obstructive pulmonary disease. Atherosclerosis Risk in
Communities Study Investigators. N Engl J Med 1994;331:228-33. 8. Maes M, Christophe A, Bosmans E, et al. In humans, serum
polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to
psychological stress. Biol Psychiatry 2000;47:910-20. 9. DiGiacoma RA, Kremer JM, Shah DM. Fish-oil dietary supplementation in
patients with Raynaud’s phenomenon: a double-blind, controlled, prospective study.
Am J Med 1989;86:158-64. 10. Laugharne JDE, Mellor JE, Peet M. Fatty acids and
schizophrenia.Lipids 1996;31:S163-5. 11. Fenton WS, Dickerson F, Boronow J, et al. A placebo-controlled trial
of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and
cognitive impairment in schizophrenia. Am J Psychiatry 2001;158:2071-4. 12. Alexander JW. Immunonutrition: the role of omega-3 fatty
acids.Nutr 1998;14:627-33. 13. Braden LM, Carroll KK. Dietary polyunsaturated fat in relation to
mammary carcinogenesis in rats. Lipids 1986;21(4):285. 14. O’Connor TP, Roebuck BD, Peterson F, et al. Effect of dietary
intake of fish oil and fish protein on the development of L-azaserine-induced preneoplastic
lesions in the rat pancreas. J Natl Cancer Inst 1985;75:959-62. 15. Gonzalez MJ. Fish oil, lipid peroxidation and mammary tumor growth.
J Am Coll Nutr 1995;14:325. 16. Zhu ZR, Mannisto JAS, Pietinene P, et al. Fatty acid composition of
breast adipose tissue in breast cancer patients and patients with benign breast disease.
Nutr Cancer 1995;24:151-60. 17. Nair SSD, Leitch JW, Falconer J, Garg ML. Prevention of cardiac
arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J
Nutr 1997;127:383-93. 18. Maes M, Smith R, Christophe A, et al. Fatty acid composition in major
depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega
6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord
1996;38:35–46. 19. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty
acid levels in the diet and in red blood cell membranes of depressed patients. J Affect
Disord 1998;48:149–55. 20. Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid
levels in red blood cell membranes of depressive patients. Biol Psychiatry
1998;43:315–9. 21. Maes M, Christophe A, Delanghe J, et al. Lowered omega 3
polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed
patients. Psychiatry Res 1999;85:275–91. 22. Navarro E, Esteve M, Olivé A, et al. Abnormal fatty acid pattern
in rheumatoid arthritis. A rationale for treatment with marine and botanical lipids. J
Rheumatol 2000;27:298–303. 23. Belluzzi A, Brignola C, Campieri M, et al. Effects of new fish oil
derivative on fatty acid phospholipid-membrane pattern in a group of Crohn’s disease
patients. Dig Dis Sci 1994;39:2589–94. 24. Burns CP, Halabi S, Clamon GH, et al. Phase I clinical study of fish
oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study
9473. Clin Cancer Res 1999;5:3942–7. 25. Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. N
Engl J Med 1988;318:549–57. 26. Malasanos TH, Stacpoole PW. Biological effects of omega-3 fatty acids
in diabetes mellitus. Diabetes Care 1991;14:1160–79. 27. Schectman G, Kaul S, Kassebah AH. Effect of fish oil concentrate on
lipoprotein composition in NIDDM. Diabetes 1988; 37:1567–73. 28. Toft I, Bonaa KH, Ingebretsen OC, et al. Effects of n-3
polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential
hypertension. Ann Intern Med 1995;123:911–8. 29. Luostarinen R, Wallin R, Wibell L, et al. Vitamin E supplementation
counteracts the fish oil-induced increase of blood glucose in humans. Nutr Res 1995;
15:953–68. 30. Dunstan DW, Burke V, Mori TA, et al. The independent and combined
effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in
NIDDM. Diabetes Care 1997; 20:913–21. 31. Harris WS, Zucker ML, Dujovne CA. Omega-3 fatty acids in type IV
hyperlipidemia: fish oils vs methyl esters. Am J Clin Nutr 1987;45:858 [abstr]. 32. Sheehan JP, Wei IW, Ulchaker M, Tserng KY. Effect of high fiber
intake in fish oil-treated patients with non-insulin-dependent diabetes mellitus Am J Clin
Nutr 1997; 66:1183–7. 33. Adler AJ, Holub BJ. Effect of garlic and fish-oil supplementation on
serum lipid and lipoprotein concentrations in hypercholesterolemic men. Am J Clin
Nutr 1997; 65:445–50. |